SCHEMBL5589554

SCHEMBL5589554

CCCCCc1c(OC(=O)O)c(O)c(OCC)c(OCC)c1OCC

nearest known ligand 0.35

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 5/20 0.35
FFAR1 O14842 1/20 0.31
ALDH1A1 P00352 3/20 0.31
SCD O00767 1/20 0.31
PPARG P37231 2/20 0.31
PPARA Q07869 2/20 0.31
KDM4E B2RXH2 1/20 0.31
GAA P10253 1/20 0.31
HPGD P15428 1/20 0.31
HSD17B10 Q99714 1/20 0.31
HCAR3 P49019 1/20 0.31
HCAR2 Q8TDS4 1/20 0.31
PTPN1 P18031 1/20 0.30
PPARD Q03181 1/20 0.30
PLA2G2A P14555 1/20 0.30
PLA2G5 P39877 1/20 0.30
ATM Q13315 1/20 0.30
PTGES O14684 1/20 0.30
TOP2A P11388 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5587264 0.99 ALOX5 (0.37) ALOX5ALDH1A1SCDPPARGPPARA
SCHEMBL5590426 0.99 ALOX5 (0.37) ALOX5ALDH1A1SCDPPARGPPARA
SCHEMBL5587562 0.99 ALOX5 (0.37) ALOX5ALDH1A1SCDPPARGPPARA
SCHEMBL5586960 0.99 ALOX5 (0.37) ALOX5ALDH1A1SCDPPARGPPARA
SCHEMBL5589816 0.99 ALOX5 (0.37) ALOX5ALDH1A1SCDPPARGPPARA
SCHEMBL5587164 0.95 FFAR1 (0.35) ALOX5FFAR1HPGD
SCHEMBL5587478 0.90 THRA (0.40) ALOX5PLA2G2A
SCHEMBL5588104 0.90 THRA (0.35) ALOX5PLA2G2A
SCHEMBL5589591 0.90 THRB (0.38) ALOX5
SCHEMBL5589706 0.89 CYSLTR2 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 ALOX5 188/4885FFAR1 2521/4885ALDH1A1 2181/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.